Gradual decline in the age-adjusted in-hospital mortality rate from STEMI-related cardiogenic shock irrespective of cause, race or gender with persistent higher mortality rates in women despite multivariate adjustment

Journal of Invasive Cardiology

Volumn 26, Issue 1, 2014, Pages 7-12

  Movahed, Mohammad Reza ^a,b,c   Khan, Muhammad F ^b   Hashemzadeh, Mehrtash ^d   Hashemzadeh, Mehrnoosh ^c  

^a CareMore   (United States)

^b SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d VA LONG BEACH HEALTHCARE SYSTEM   (United States)

Author keywords

Acute coronary syndrome; Acute myocardial infarction; Cardiogenic shock; Cardiovascular disease; Coronary artery disease incidence; Epidemiology; Shock; ST elevation myocardial infarction

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; CARDIOGENIC SHOCK; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CHRONIC KIDNEY FAILURE; CORONARY ARTERY DISEASE; DETERIORATION; ETHNICITY; FEMALE; GENDER; HEART FAILURE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; HYPERLIPIDEMIA; ICD-9; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PULMONARY HYPERTENSION; RACE; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; UNITED STATES; VERY ELDERLY;

AFRICAN AMERICANS; AGE FACTORS; AGED; AGED, 80 AND OVER; CONTINENTAL POPULATION GROUPS; ELECTROCARDIOGRAPHY; EUROPEAN CONTINENTAL ANCESTRY GROUP; EVIDENCE-BASED MEDICINE; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PROGNOSIS; RETROSPECTIVE STUDIES; SEX FACTORS; SHOCK, CARDIOGENIC; SURVIVAL RATE; UNITED STATES;

EID: 84892178932     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Movahed MR, John J, Hashemzadeh M, Jamal MM. Trends in the age adjusted mortality from acute ST segment elevation myocardial infarction in the united states (1988-2004) based on race, gender, infarct location and comorbidities. Am J Cardiol. 2009;104(8):1030- 1034.
2. Movahed MR, Ramaraj R, Hashemzadeh M, Jamal MM. Rate of acute ST-elevation myocardial infarction in the United States from 1988 to 2004 (from the nationwide inpatient sample). Am J Cardiol. 2009;104(1):5-8.
3. Movahed MR, John J, Hashemzadeh M. Mortality trends for non-st-segment elevation myocardial infarction (nstemi) in the united states from 1988 to 2004. Clin Cardiol. 2011;34(11):689-692.
4. Becker RC, Gore JM, Lambrew C, et al. A composite view of cardiac rupture in the united states national registry of myocardial infarction. J Am Coll Cardiol. 1996;27(6):1321-1326.
5. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. Shock investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med. 1999;341(9):625-634.
6. Babaev A, Frederick PD, Pasta DJ, Every N, Sichrovsky T, Hochman JS. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA. 2005;294(4):448-454.
7. Holmes DR Jr, Bates ER, Kleiman NS, et al. Contemporary reperfusion therapy for cardiogenic shock: The GUSTO-I trial experience. The GUSTO-I investigators. Global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries. J Am Coll Cardiol. 1995;26(3):668-674.
8. Hasdai D, Harrington RA, Hochman JS, et al. Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation. J Am Coll Cardiol. 2000;36(3):685-692.
9. Hochman JS, Boland J, Sleeper LA, et al. Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an international registry. Shock registry investigators. Circulation. 1995;91(3):873-881.
10. Goldberg RJ, Spencer FA, Gore JM, Lessard D, Yarzebski J. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation. 2009;119(9):1211-1219.
11. Ryan TJ, Antman EM, Brooks NH, et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee on management of acute myocardial infarction). J Am Coll Cardiol. 1999;34(3):890-911.
12. Kushner FG, Hand M, Smith SC Jr, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation. 2009;120(22):2271-2306.
13. Carruthers KF, Dabbous OH, Flather MD, et al. Contemporary management of acute coronary syndromes: does the practice match the evidence? The global registry of acute coronary events (GRACE). Heart. 2005;91(3):290-298.
14. Fox KA, Goodman SG, Anderson FA Jr, et al. From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The global registry of acute coronary events (GRACE). Eur Heart J. 2003;24(15):1414-1424.
15. Lindholm MG, Kober L, Boesgaard S, Torp-Pedersen C, Aldershvile J. Cardiogenic shock complicating acute myocardial infarction; prognostic impact of early and late shock development. Eur Heart J. 2003;24(3):258-265.
16. Reynolds HR, Hochman JS. Cardiogenic shock: current concepts and improving outcomes. Circulation. 2008;117(5):686-697.
17. Conde-Vela C, Moreno R, Hernandez R, et al. Cardiogenic shock at admission in patients with multivessel disease and acute myocardial infarction treated with percutaneous coronary intervention: related factors. Int J Cardiol. 2007;123(1):29-33.
18. Page DL, Caulfield JB, Kastor JA, DeSanctis RW, Sanders CA. Myocardial changes associated with cardiogenic shock. N Engl J Med. 1971;285(3):133-137.
19. Hasdai D, Holmes DR Jr, Califf RM, et al. Cardiogenic shock complicating acute myocardial infarction: predictors of death. GUSTO investigators. Global utilization of streptokinase and tissue-plasminogen activator for occluded coronary arteries. Am Heart J. 1999;138(1 Pt 1):21-31.
20. Picard MH, Davidoff R, Sleeper LA, et al. Echocardiographic predictors of survival and response to early revascularization in cardiogenic shock. Circulation. 2003;107(2):279-284.
21. Sanborn TA, Sleeper LA, Webb JG, et al. Correlates of one-year survival inpatients with cardiogenic shock complicating acute myocardial infarction: angiographic findings from the shock trial. J Am Coll Cardiol. 2003;42(8):1373-1379.
22. Mehta RH, Ou FS, Peterson ED, et al. Clinical significance of post-procedural timi flow in patients with cardiogenic shock undergoing primary percutaneous coronary intervention. JACC Cardiovasc Interv. 2009;2(1):56-64.
23. Engstrom AE, Vis MM, Bouma BJ, et al. Right ventricular dysfunction is an independent predictor for mortality in ST-elevation myocardial infarction patients presenting with cardiogenic shock on admission. Eur J Heart Fail. 2010;12(3):276-282.
24. Bengtson JR, Kaplan AJ, Pieper KS, et al. Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era. J Am Coll Cardiol. 1992;20(7):1482- 1489.
25. Hochman JS, Sleeper LA, White HD, et al. One-year survival following early revascularization for cardiogenic shock. JAMA. 2001;285(2):190-192.
26. Boersma E, Maas AC, Deckers JW, Simoons ML. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet. 1996;348(9030):771- 775.
27. Brodie BR, Stuckey TD, Wall TC, et al. Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 1998;32(5):1312-1319.
28. Cannon CP, Gibson CM, Lambrew CT, et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA. 2000;283(22):2941-2947.
29. McNamara RL, Wang Y, Herrin J, et al. Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2006;47(11):2180-2186.
30. Berrocal DH, Cohen MG, Spinetta AD, et al. Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase. Am Heart J. 2003;146(6):E22.
31. Lindholm MG, Boesgaard S, Thune JJ, Kelbaek H, Andersen HR, Kober L. Percutaneous coronary intervention for acute MI does not prevent in-hospital development of cardiogenic shock compared to fibrinolysis. Eur J Heart Fail. 2008;10(7):668-674.
32. Klein LW, Shaw RE, Krone RJ, et al. Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model. Am J Cardiol. 2005;96(1):35-41.
33. Hochman JS. Cardiogenic shock complicating acute myocardial infarction: Expanding the paradigm. Circulation. 2003;107(24):2998-3002.
34. Kohsaka S, Menon V, Lowe AM, et al. Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch Intern Med. 2005;165(14):1643-1650.
35. Menon V, Slater JN, White HD, Sleeper LA, Cocke T, Hochman JS. Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK trial registry. Am J Med. 2000;108(5):374-380.
36. Vis MM, Engstrom AE, Sjauw KD, et al. Plasma glucose and not hemoglobin or renal function predicts mortality in patients with STEMI complicated with cardiogenic shock. J Cardiovasc Med (Hagerstown). 2010;11(11):827-831.
37. Valente S, Lazzeri C, Vecchio S, et al. Predictors of in-hospital mortality after percutaneous coronary intervention for cardiogenic shock. Int J Cardiol. 2007;114(2):176-182.
38. Movahed MR, Hashemzadeh M, Jamal MM, Ramaraj R. Decreasing in-hospital mortality of patients undergoing percutaneous coronary intervention with persistent higher mortality rates in women and minorities in the united states. J Invasive Cardiol. 2010;22(2):58-60.
39. Kralev S, Hennig O, Lang S, et al. Sex-based differences in clinical and angiographic outcomes in patients with ST-elevation myocardial infarction treated with concomitant use of glycoprotein IIb/IIIa inhibitors. Cardiol J. 2010;17(6):580-586.
40. Benamer H, Tafflet M, Bataille S, et al. Female gender is an independent predictor of in-hospital mortality after STEMI in the era of primary PCI: Insights from the greater paris area PCI registry. EuroIntervention. 2011;6(9):1073- 1079.
41. Bertoni AG, Goonan KL, Bonds DE, Whitt MC, Goff DC Jr, Brancati FL. Racial and ethnic disparities in cardiac catheterization for acute myocardial infarction in the united states, 1995-2001. J Natl Med Assoc. 2005;97(3):317-323.
42. Bradley EH, Herrin J, Wang Y, et al. Racial and ethnic differences in time to acute reperfusion therapy for patients hospitalized with myocardial infarction. JAMA. 2004;292(13):1563-1572.